June 2019
Two Sides - Myths & Facts
The Myths & Facts booklet busts 9 of the biggest myths about print and paper.
When it comes to the sustainability of Print and Paper, it's important to separate the Facts from the Myths. The European paper industry is a world-leader when it comes to sustainably-sourced raw materials, renewable energy and recycling rates.
Yet the myths around paper are still prevalent amongst consumers. A 2019 survey by Two Sides revealed 59% of European consumers believe European forests are shrinking, when in fact they have been growing by an area equivalent to 1,500 football pitches every day. A third of consumers believe paper is a wasteful product and a quarter believe paper is bad for the environment.
Often the source of these misconceptions is the abundance of misleading information about paper and its impact on the environment.
Paper has been the preferred communications medium for 2,000 years. Even in today's digital world, it continues to be highly effective and, produced, used and disposed of responsibly, is inherently sustainable.
Two Sides seeks to ensure that, by fostering a better understanding of our industry's environmental credentials, Print and Paper, through its myriad of uses, from commercial applications to the basis of learning and creativity, remains an essential medium for many generations to come.
Download the Myths & Facts booklet from the Two Sides website using the link below.
DownloadsIntergraf Economic News (Paper Prices) - March 2024
March 2024
Access the latest edition of the Economic Newsletter for the European Printing Industry for data on paper consumption, and pricing data for pulp, paper and recovered paper. Data for packaging papers and board is also available with this edition.
STUDY EXPOSES HIGH COST OF PHARMACIES PRINTING MEDICAL INFORMATION LEAFLETS
March 2024
Intergraf welcomes the release of a study by our partner MLPS (Medical Leaflet = Patient Safety), a subgroup of the European Carton Manufacturers Association (ECMA) shedding light on the potential economic costs associated with the proposed use of Print on Demand (PoD) leaflets in the pharmaceutical legislation revision.